Proteome Sciences (PRM)
PRM Share PerformanceMore
|52 week high||23.940 21/04/16|
|52 week low||9.000 21/09/16|
|52 week change||-4.500 (-28.80%)|
|4 week volume||7,126,761 04/09/16|
Media for (PRM)
Latest News« previous» nextMore
29/09/2016 - 07:00 RNS
RNS Number: 1393L Proteome Sciences PLC 29 September 2016 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii PROTEOME SCIENCES 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting rights...
22/09/2016 - 16:55 StockMarketWire
The blue chip index's rally continued as higher commodity prices attracted investors to resources stocks. The FTSE 100 close...
22/09/2016 - 07:00 RNS
RNS Number: 5050K Proteome Sciences PLC 22 September 2016 PRESS RELEASE Proteome Sciences plc Study Demonstrates Mass Spectrometry Technique Dramatically Enhances Detection of Key Early Stage Alzheimer's Biomarkers. Publication: Journal of Alzheimer's disease For immediate release: 22nd September 2016, Cobham, UK: A peer reviewed study led b...
15/09/2016 - 07:10 StockMarketWire
Proteome Sciences said revenues to 30 June increased 32% to 1.12 million (2015: 0.85 million). Licences/sales/services revenues...
15/09/2016 - 07:00 RNS
RNS Number: 8681J Proteome Sciences PLC 15 September 2016 15 th September 2016 Proteome Sciences plc ("Proteome Sciences" or the "Company") INTERIM RESULTS Proteome Sciences today releases its unaudited interim results for the six months ended 30 th June 2016. Financial highlights: Revenues to 30 th June increased 32% to 1.12m (2015: 0.85m) Licences/sales/...
28/07/2016 - 09:05 StockMarketWire
Proteome Sciences said revenues in the first half were significantly ahead of the equivalent period in 2015 driven principal...
28/07/2016 - 07:00 RNS
RNS Number: 4575F Proteome Sciences PLC 28 July 2016 Proteome Sciences plc (the "Company" or the "Group") Trading Update and Notice of Results The Company is pleased to provide a trading update for the six months ending 30 th June 2016. Revenues in the first half are significantly ahead of the equivalent period in 2015 driven principally by strong sales of ou...
24/06/2016 - 13:16 StockMarketWire
Proteome Sciences is on track to deliver a significant increase in revenues, shareholders at the annual general meeting were...
|Dividend yield||0 %|
Equity Research (PRM)
Proteome Sciences plc
Edison Investment Research is terminating coverage on Proteome Sciences (PRM). Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now...
Proteome Sciences plc
Proteome Sciences signed its first major biomarker service contract in September. This followed on from the data from the 1,148-patient Alzheimer’s disease (AD) study, which could lead to a blood-...
Latest discussion posts More
“No irony intended. Sarcasm maybe. Regarding info on holdings, I asked you for the same some time ago! TP”▼
“WP/TP - its fascinating you are so fixated with my view of PRM, but so rarely discuss PRM. How many PRM shares do you hold, at what average price, and for how long? Now ...”▼
“If it's a move up in the SP, it's ALWAYS "market sentiment"! :)”▼
Codes & Symbols
|Symbols||PRM, LSE:PRM, PRM.L, PRM:LN, LON:PRM, XLON:PRM|